PDZ domains and their binding partners: Structure, specificity, and modification

Cell Communication and Signaling

Volumn 8, Issue , 2010, Pages

  Lee, Ho Jin ^a   Zheng, Jie J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952705907     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-8-8     Document Type: Review

References (189)

1. Dynamic control of signaling by modular adaptor proteins. T Pawson, Curr Opin Cell Biol 2007 19 112 116 10.1016/j.ceb.2007.02.013 17317137
2. Assembly of cell regulatory systems through protein interaction domains. T Pawson, P Nash, Science 2003 300 445 452 10.1126/science.1083653 12702867
3. Origin of PDZ (DHR, GLGF) domains. MB Kennedy, Trends Biochem Sci 1995 20 350 10.1016/S0968-0004(00)89074-X 7482701
4. Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ. DA Doyle, A Lee, J Lewis, E Kim, M Sheng, R MacKinnon, Cell 1996 85 1067 1076 10.1016/S0092-8674(00)81307-0 8674113
5. Crystal structure of a PDZ domain. JH Morais Cabral, C Petosa, MJ Sutcliffe, S Raza, O Byron, F Poy, SM Marfatia, AH Chishti, RC Liddington, Nature 1996 382 649 652 10.1038/382649a0 8757139
6. Evidence for PDZ domains in bacteria, yeast, and plants. CP Ponting, Protein Sci 1997 6 464 468 9041651
7. Act globally, think locally: systems biology addresses the PDZ domain. MR Spaller, ACS Chem Biol 2006 1 207 210 10.1021/cb600191y 17163673
8. PDZ domains in synapse assembly and signalling. CC Garner, J Nash, RL Huganir, Trends Cell Biol 2000 10 274 280 10.1016/S0962-8924(00)01783-9 10856930
9. PDZ domains and the organization of supramolecular complexes. M Sheng, C Sala, Annu Rev Neurosci 2001 24 1 29 10.1146/annurev.neuro.24.1.1 11283303
10. Mechanism and role of PDZ domains in signaling complex assembly. BZ Harris, WA Lim, J Cell Sci 2001 114 3219 3231 11591811
11. PDZ domains: More than just a glue. I Bezprozvanny, A Maximov, Proc Natl Acad Sci USA 2001 98 787 789 10.1073/pnas.98.3.787 11158544
12. Signaling complex organization by PDZ domain proteins. JS Fan, M Zhang, Neurosignals 2002 11 315 321 10.1159/000068256 12566920
13. PDZ domains: structural modules for protein complex assembly. AY Hung, M Sheng, J Biol Chem 2002 277 5699 5702 10.1074/jbc.R100065200 11741967
14. Organization of signaling complexes by PDZ-domain scaffold proteins. M Zhang, W Wang, Acc Chem Res 2003 36 530 538 10.1021/ar020210b 12859214
15. PDZ domains-glue and guide. HM van, W Hendriks, Mol Biol Rep 2003 30 69 82 10.1023/A:1023941703493 12841577
16. Composition and function of PDZ protein complexes during cell polarization. MH Roh, B Margolis, Am J Physiol Renal Physiol 2003 285 377 F387 12890661
17. Structure and function of HtrA family proteins, the key players in protein quality control. DY Kim, KK Kim, J Biochem Mol Biol 2005 38 266 274 15943900
18. PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. B Brone, J Eggermont, Am J Physiol Cell Physiol 2005 288 20 C29 15591244
19. PDZ domain protein-protein interactions: a case study with PICK1. KK Dev, Curr Top Med Chem 2007 7 3 20 10.2174/156802607779318343 17266593
20. Hidden dynamic allostery in a PDZ domain. CM Petit, J Zhang, PJ Sapienza, EJ Fuentes, AL Lee, Proc Natl Acad Sci USA 2009 106 18249 18254 10.1073/pnas.0904492106 19828436
21. Protein-protein interactions: PDZ domain networks. AS Fanning, JM Anderson, Curr Biol 1996 6 1385 1388 10.1016/S0960-9822(96)00737-3 8939589
22. PDZ domains bind carboxy-terminal sequences of target proteins. J Saras, CH Heldin, Trends Biochem Sci 1996 21 455 458 10.1016/S0968-0004(96)30044-3 9009824
23. Peptide recognition by PTB and PDZ domains. D Cowburn, Curr Opin Struct Biol 1997 7 835 838 10.1016/S0959-440X(97)80155-8 9434904
24. A molecular-properties-based approach to understanding PDZ domain proteins and PDZ ligands. C Giallourakis, Z Cao, T Green, H Wachtel, X Xie, M Lopez-Illasaca, M Daly, J Rioux, R Xavier, Genome Res 2006 16 1056 1072 10.1101/gr.5285206 16825666
25. Therapeutic use of PDZ protein-protein interaction antagonism. NX Wang, HJ Lee, JJ Zheng, Drug News Perspect 2008 21 137 141 18560611
26. PDBsum more: new summaries and analyses of the known 3D structures of proteins and nucleic acids. RA Laskowski, VV Chistyakov, JM Thornton, Nucleic Acids Res 2005 33 266 D268 10.1093/nar/gki001 15608193
27. Thermodynamic basis for promiscuity and selectivity in protein-protein interactions: PDZ domains, a case study. N Basdevant, H Weinstein, M Ceruso, J Am Chem Soc 2006 128 12766 12777 10.1021/ja060830y 17002371
28. P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2. SR Fam, M Paquet, AM Castleberry, H Oller, CJ Lee, SF Traynelis, Y Smith, CC Yun, RA Hall, Proc Natl Acad Sci USA 2005 102 8042 8047 10.1073/pnas.0408818102 15901899
29. The PDZ scaffold NHERF-2 interacts with mGluR5 and regulates receptor activity. M Paquet, MJ Asay, SR Fam, H Inuzuka, AM Castleberry, H Oller, Y Smith, CC Yun, SF Traynelis, RA Hall, J Biol Chem 2006 281 29949 29961 10.1074/jbc.M602262200 16891310
30. Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. J He, M Bellini, H Inuzuka, J Xu, Y Xiong, X Yang, AM Castleberry, RA Hall, J Biol Chem 2006 281 2820 2827 10.1074/jbc.M509503200 16316992
31. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Z Songyang, AS Fanning, C Fu, J Xu, SM Marfatia, AH Chishti, A Crompton, AC Chan, JM Anderson, LC Cantley, Science 1997 275 73 77 10.1126/science.275.5296.73 8974395
32. Analysis of PDZ domain-ligand interactions using carboxyl-terminal phage display. G Fuh, MT Pisabarro, Y Li, C Quan, LA Lasky, SS Sidhu, J Biol Chem 2000 275 21486 21491 10887205
33. Engineering M13 for phage display. SS Sidhu, Biomol Eng 2001 18 57 63 10.1016/S1389-0344(01)00087-9 11535417
34. Target-assisted iterative screening reveals novel interactors for PSD95, Nedd4, Src, Abl and Crk proteins. A Kurakin, D Bredesen, J Biomol Struct Dyn 2002 19 1015 1029 12023804
35. Exploring protein-protein interactions with phage display. SS Sidhu, WJ Fairbrother, K Deshayes, Chembiochem 2003 4 14 25 10.1002/cbic.200390008 12512072
36. Comparative structural analysis of the Erbin PDZ domain and the first PDZ domain of ZO-1. Insights into determinants of PDZ domain specificity. BA Appleton, Y Zhang, P Wu, JP Yin, W Hunziker, NJ Skelton, SS Sidhu, C Wiesmann, J Biol Chem 2006 281 22312 22320 10.1074/jbc.M602901200 16737969
37. Phage display for engineering and analyzing protein interaction interfaces. SS Sidhu, S Koide, Curr Opin Struct Biol 2007 17 481 487 10.1016/j.sbi.2007.08.007 17870470
38. Characterization of a Putative Phosphorylation Switch: Adaptation of SPOT Synthesis to Analyze PDZ Domain Regulation Mechanisms. P Boisguerin, B Ay, G Radziwill, RD Fritz, K Moelling, R Volkmer, Chembiochem 2007 17973281
39. The PDZ domain as a complex adaptive system. A Kurakin, A Swistowski, SC Wu, DE Bredesen, PLoS ONE 2007 2 953 10.1371/journal.pone.0000953 17895993
40. An allosteric intramolecular PDZ-PDZ interaction modulates PTP-BL PDZ2 binding specificity. LC van den Berk, E Landi, T Walma, GW Vuister, L Dente, WJ Hendriks, Biochemistry 2007 46 13629 13637 10.1021/bi700954e 17979300
41. Structural and functional analysis of the PDZ domains of human HtrA1 and HtrA3. ST Runyon, Y Zhang, BA Appleton, SL Sazinsky, P Wu, B Pan, C Wiesmann, NJ Skelton, SS Sidhu, Protein Sci 2007 16 2454 2471 10.1110/ps.073049407 17962403
42. Structural and functional analysis of the ligand specificity of the HtrA2/Omi PDZ domain. Y Zhang, BA Appleton, P Wu, C Wiesmann, SS Sidhu, Protein Sci 2007 16 1738 1750 10.1110/ps.072833207 17656586
43. Synthesis and screening of support-bound combinatorial Peptide libraries with free C-termini: determination of the sequence specificity of PDZ domains. SH Joo, D Pei, Biochemistry 2008 47 3061 3072 10.1021/bi7023628 18232644
44. The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling. PR Cushing, A Fellows, D Villone, P Boisguerin, DR Madden, Biochemistry 2008 47 10084 10098 10.1021/bi8003928 18754678
45. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands. FC Morales, Y Takahashi, S Momin, H Adams, X Chen, MM Georgescu, Mol Cell Biol 2007 27 2527 2537 10.1128/MCB.01372-06 17242191
46. Identification of tripeptides recognized by the PDZ domain of Dishevelled. H-J Lee, NX Wang, Y Shao, JJ Zheng, Bioorg Med Chem 2009 17 1701 1708 10.1016/j.bmc.2008.12.060 19157887
47. Sulindac inhibits canonical Wnt signaling by blocking the PDZ domain of the protein Dishevelled. HJ Lee, NX Wang, DL Shi, JJ Zheng, Angew Chem Int Ed Engl 2009 48 6448 6452 10.1002/anie.200902981 19637179
48. Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled. HC Wong, A Bourdelas, A Krauss, HJ Lee, Y Shao, D Wu, M Mlodzik, DL Shi, J Zheng, Mol Cell 2003 12 1251 1260 10.1016/S1097-2765(03)00427-1 14636582
49. Inhibition of Wnt signaling by Dishevelled PDZ peptides. Y Zhang, BA Appleton, C Wiesmann, T Lau, M Costa, RN Hannoush, SS Sidhu, Nat Chem Biol 2009 5 217 219 10.1038/nchembio.152 19252499
50. Crystal structure of the Shank PDZ-ligand complex reveals a class I PDZ interaction and a novel PDZ-PDZ dimerization. YJ Im, JH Lee, SH Park, SJ Park, SH Rho, GB Kang, E Kim, SH Eom, J Biol Chem 2003 278 48099 48104 10.1074/jbc.M306919200 12954649
51. Crystal structure of GRIP1 PDZ6-peptide complex reveals the structural basis for class II PDZ target recognition and PDZ domain-mediated multimerization. YJ Im, SH Park, SH Rho, JH Lee, GB Kang, M Sheng, E Kim, SH Eom, J Biol Chem 2003 278 8501 8507 10.1074/jbc.M212263200 12493751
52. Dimerization of the scaffolding protein ZO-1 through the second PDZ domain. DI Utepbergenov, AS Fanning, JM Anderson, J Biol Chem 2006 281 24671 24677 10.1074/jbc.M512820200 16790439
53. Domain-swapped dimerization of the second PDZ domain of ZO2 may provide a structural basis for the polymerization of claudins. J Wu, Y Yang, J Zhang, P Ji, W Du, P Jiang, D Xie, H Huang, M Wu, G Zhang, J Wu, Y Shi, J Biol Chem 2007
54. Domain swapping within PDZ2 is responsible for dimerization of ZO proteins. AS Fanning, MF Lye, JM Anderson, L Arnon, J Biol Chem 2007 17928286
55. Domain-swapped dimerization of ZO-1 PDZ2 generates specific and regulatory connexin43-binding sites. J Chen, L Pan, Z Wei, Y Zhao, M Zhang, EMBO J 2008 27 2113 2123 10.1038/emboj.2008.138 18636092
56. Supramodular nature of GRIP1 revealed by the structure of its PDZ12 tandem in complex with the carboxyl tail of Fras1. J Long, Z Wei, W Feng, C Yu, YX Zhao, M Zhang, J Mol Biol 2008 375 1457 1468 10.1016/j.jmb.2007.11.088 18155042
57. Tandem PDZ repeats in glutamate receptor-interacting proteins have a novel mode of PDZ domain-mediated target binding. W Feng, Y Shi, M Li, M Zhang, Nat Struct Biol 2003 10 972 978 10.1038/nsb992 14555997
58. Supramodular structure and synergistic target binding of the N-terminal tandem PDZ domains of PSD-95. JF Long, H Tochio, P Wang, JS Fan, C Sala, M Niethammer, M Sheng, M Zhang, J Mol Biol 2003 327 203 214 10.1016/S0022-2836(03) 00113-X 12614619
59. PDZ tandem of human syntenin: crystal structure and functional properties. BS Kang, DR Cooper, F Jelen, Y Devedjiev, U Derewenda, Z Dauter, J Otlewski, ZS Derewenda, Structure 2003 11 459 468 10.1016/S0969-2126(03)00052-2 12679023
60. The binding of the PDZ tandem of syntenin to target proteins. J Grembecka, T Cierpicki, Y Devedjiev, U Derewenda, BS Kang, JH Bushweller, ZS Derewenda, Biochemistry 2006 45 3674 3683 10.1021/bi052225y 16533050
61. Autoinhibition of X11/Mint scaffold proteins revealed by the closed conformation of the PDZ tandem. JF Long, W Feng, R Wang, LN Chan, FC Ip, J Xia, NY Ip, M Zhang, Nat Struct Mol Biol 2005 12 722 728 10.1038/nsmb958 16007100
62. GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. H Dong, RJ O'Brien, ET Fung, AA Lanahan, PF Worley, RL Huganir, Nature 1997 386 279 284 10.1038/386279a0 9069286
63. Organization and dynamics of PDZ-domain-related supramodules in the postsynaptic density. W Feng, M Zhang, Nat Rev Neurosci 2009 10 87 99 10.1038/nrn2540 19153575
64. Experimentally observed conformation-dependent geometry and hidden strain in proteins. PA Karplus, Protein Sci 1996 5 1406 1420 10.1002/pro.5560050719 8819173
65. Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation. BN Cheyette, JS Waxman, JR Miller, K Takemaru, LC Sheldahl, N Khlebtsova, EP Fox, T Earnest, RT Moon, Dev Cell 2002 2 449 461 10.1016/S1534-5807(02)00140-5 11970895
66. Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. BJ Hillier, KS Christopherson, KE Prehoda, DS Bredt, WA Lim, Science 1999 284 812 815 10.1126/science.284.5415.812 10221915
67. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. JE Brenman, DS Chao, SH Gee, AW McGee, SE Craven, DR Santillano, Z Wu, F Huang, H Xia, MF Peters, SC Froehner, DS Bredt, Cell 1996 84 757 767 10.1016/S0092-8674(00)81053- 3 8625413
68. Cyclic peptides as non-carboxyl-terminal ligands of syntrophin PDZ domains. SH Gee, SA Sekely, C Lombardo, A Kurakin, SC Froehner, BK Kay, J Biol Chem 1998 273 21980 21987 10.1074/jbc.273.34.21980 9705339
69. Internal recognition through PDZ domain plasticity in the Par-6-Pals1 complex. RR Penkert, HM DiVittorio, KE Prehoda, Nat Struct Mol Biol 2004 11 1122 1127 10.1038/nsmb839 15475968
70. Interaction between the internal motif KTXXXI of Idax and mDvl PDZ domain. TB London, HJ Lee, Y Shao, J Zheng, Biochem Biophys Res Commun 2004 322 326 332 10.1016/j.bbrc.2004.07.113 15313210
71. Origins of PDZ domain ligand specificity. Structure determination and mutagenesis of the Erbin PDZ domain. NJ Skelton, MF Koehler, K Zobel, WL Wong, S Yeh, MT Pisabarro, JP Yin, LA Lasky, SS Sidhu, J Biol Chem 2003 278 7645 7654 10.1074/jbc.M209751200 12446668
72. Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm. BS Kang, DR Cooper, Y Devedjiev, U Derewenda, ZS Derewenda, Structure 2003 11 845 853 10.1016/S0969-2126(03)00125- 4 12842047
73. A specificity map for the PDZ domain family. R Tonikian, Y Zhang, SL Sazinsky, B Currell, JH Yeh, B Reva, HA Held, BA Appleton, M Evangelista, Y Wu, X Xin, AC Chan, S Seshagiri, LA Lasky, C Sander, C Boone, GD Bader, SS Sidhu, PLoS Biol 2008 6 239 10.1371/journal.pbio.0060239 18828675
74. Identifying specificity profiles for peptide recognition modules from phage-displayed peptide libraries. R Tonikian, YN Zhang, C Boone, SS Sidhu, Nature Protocols 2007 2 1368 1386 10.1038/nprot.2007.151 17545975
75. Convergent and divergent ligand specificity among PDZ domains of the LAP and zonula occludens (ZO) families. Y Zhang, S Yeh, BA Appleton, HA Held, PJ Kausalya, DC Phua, WL Wong, LA Lasky, C Wiesmann, W Hunziker, SS Sidhu, J Biol Chem 2006 281 22299 22311 10.1074/jbc.M602902200 16737968
76. High-energy water sites determine peptide binding affinity and specificity of PDZ domains. T Beuming, R Farid, W Sherman, Protein Sci 2009 18 1609 1619 10.1002/pro.177 19569188
77. Functional relevance of the disulfide-linked complex of the N-terminal PDZ domain of InaD with NorpA. ME Kimple, DP Siderovski, J Sondek, EMBO J 2001 20 4414 4422 10.1093/emboj/20.16.4414 11500369
78. PDZ domains-common players in the cell signaling. F Jelen, A Oleksy, K Smietana, J Otlewski, Acta Biochim Pol 2003 50 985 1017 14739991
79. A high efficiency strategy for binding property characterization of peptide-binding domains. E Song, S Gao, R Tian, S Ma, H Huang, J Guo, Y Li, L Zhang, Y Gao, Mol Cell Proteomics 2006 5 1368 1381 10.1074/mcp.M600072-MCP200 16635984
80. Targeting the PDZ domains of molecular scaffolds of transmembrane ion channels. A Piserchio, M Spaller, DF Mierke, AAPS J 2006 8 396 E401 16796391
81. Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95. H Hering, M Sheng, FEBS Lett 2002 521 185 189 10.1016/S0014-5793(02) 02831-4 12067714
82. Two-hybrid arrays. P Uetz, Curr Opin Chem Biol 2002 6 57 62 10.1016/S1367-5931(01)00288-5 11827824
83. Proteomic approaches in drug discovery and development. HD Soares, SA Williams, PJ Snyder, F Gao, T Stiger, C Rohlff, A Herath, T Sunderland, K Putnam, WF White, Int Rev Neurobiol 2004 61 97 126 full-text 15482813
84. Analysis of PDZ domain interactions using yeast two-hybrid and coimmunoprecipitation assays. HW Lee, J Ko, E Kim, Methods Mol Biol 2006 332 233 244 16878696
85. Monitoring protein-protein interactions between the mammalian integral membrane transporters and PDZ-interacting partners using a modified split-ubiquitin membrane yeast two-hybrid system. SM Gisler, S Kittanakom, D Fuster, V Wong, M Bertic, T Radanovic, RA Hall, H Murer, J Biber, D Markovich, OW Moe, I Stagljar, Mol Cell Proteomics 2008 7 1362 1377 10.1074/mcp.M800079- MCP200 18407958
86. A class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathies. NP von, M Ismail, C Gardin, H Suila, I Zara, A Belgrano, G Valle, O Carpen, G Faulkner, Mol Cell Biol 2009 29 822 834 10.1128/MCB.01454-08 19047374
87. Dissecting protein function and signaling using protein microarrays. A Wolf-Yadlin, M Sevecka, G MacBeath, Curr Opin Chem Biol 2009 13 398 405 10.1016/j.cbpa.2009.06.027 19660979
88. Microsphere-based co-immunoprecipitation in multiplex. O Poetz, K Luckert, T Herget, TO Joos, Anal Biochem 2009 395 244 248 10.1016/j.ab.2009.08. 002 19665442
89. Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis. HW Lee, J Choi, H Shin, K Kim, J Yang, M Na, SY Choi, GB Kang, SH Eom, H Kim, E Kim, J Neurosci 2008 28 14546 14556 10.1523/JNEUROSCI.3112-08.2008 19118189
90. A novel association of mGluR1a with the PDZ scaffold protein CAL modulates receptor activity. J Zhang, S Cheng, Y Xiong, Y Ma, D Luo, A Jeromin, H Zhang, J He, FEBS Lett 2008 582 4117 4124 10.1016/j.febslet.2008.10.054 19027007
91. The tandem PDZ protein Syntenin interacts with the aminoacyl tRNA synthetase complex in a lysyl-tRNA synthetase-dependent manner. K Meerschaert, E Remue, GA De, A Staes, C Boucherie, K Gevaert, J Vandekerckhove, L Kleiman, J Gettemans, J Proteome Res 2008 7 4962 4973 10.1021/pr800325u 18839981
92. Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells. HY Gee, YW Kim, MJ Jo, W Namkung, JY Kim, HW Park, KS Kim, H Kim, A Baba, J Yang, E Kim, KH Kim, MG Lee, Gastroenterology 2009 137 607 17 617. 10.1053/j.gastro.2009.01.065 19642226
93. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. K Terpe, Appl Microbiol Biotechnol 2003 60 523 533 12536251
94. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. H Cui, A Hayashi, HS Sun, MP Belmares, C Cobey, T Phan, J Schweizer, MW Salter, YT Wang, RA Tasker, D Garman, J Rabinowitz, PS Lu, M Tymianski, J Neurosci 2007 27 9901 9915 10.1523/JNEUROSCI.1464-07.2007 17855605
95. Large-scale sequence analysis of avian influenza isolates. JC Obenauer, J Denson, PK Mehta, X Su, S Mukatira, DB Finkelstein, X Xu, J Wang, J Ma, Y Fan, KM Rakestraw, RG Webster, E Hoffmann, S Krauss, J Zheng, Z Zhang, CW Naeve, Science 2006 311 1576 1580 10.1126/science.1121586 16439620
96. A new influenza virus virulence determinant: The NS1 protein four C-terminal residues modulate pathogenicity. D Jackson, MJ Hossain, D Hickman, DR Perez, RA Lamb, Proc Natl Acad Sci USA 2008 105 4381 4386 10.1073/pnas. 0800482105 18334632
97. PDZ domain binding selectivity is optimized across the mouse proteome. MA Stiffler, JR Chen, VP Grantcharova, Y Lei, D Fuchs, JE Allen, LA Zaslavskaia, G MacBeath, Science 2007 317 364 369 10.1126/science.1144592 17641200
98. Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays. MA Stiffler, VP Grantcharova, M Sevecka, G MacBeath, J Am Chem Soc 2006 128 5913 5922 10.1021/ja060943h 16637659
99. Predicting PDZ domain-peptide interactions from primary sequences. JR Chen, BH Chang, JE Allen, MA Stiffler, G MacBeath, Nat Biotechnol 2008 26 1041 1045 10.1038/nbt.1489 18711339
100. A high efficiency strategy for binding property characterization of peptide-binding domains. E Song, S Gao, R Tian, S Ma, H Huang, J Guo, Y Li, L Zhang, Y Gao, Mol Cell Proteomics 2006 5 1368 1381 10.1074/mcp.M600072-MCP200 16635984
101. Functional genomics of intracellular peptide recognition domains with combinatorial biology methods. SS Sidhu, GD Bader, C Boone, Curr Opin Chem Biol 2003 7 97 102 10.1016/S1367-5931(02)00011-X 12547433
102. Redox-regulated affinity of the third PDZ domain in the phosphotyrosine phosphatase PTP-BL for cysteine-containing target peptides. LC van den Berk, E Landi, E Harmsen, L Dente, WJ Hendriks, FEBS J 2005 272 3306 3316 10.1111/j.1742-4658.2005.04743.x 15978037
103. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides. U Wiedemann, P Boisguerin, R Leben, D Leitner, G Krause, K Moelling, R Volkmer-Engert, H Oschkinat, J Mol Biol 2004 343 703 718 10.1016/j.jmb.2004.08.064 15465056
104. Binding of Vac14 to neuronal nitric oxide synthase: Characterisation of a new internal PDZ-recognition motif. JF Lemaire, PS McPherson, FEBS Lett 2006 580 6948 6954 10.1016/j.febslet.2006.11.061 17161399
105. An evaluation of human protein-protein interaction data in the public domain. S Mathivanan, B Periaswamy, TK Gandhi, K Kandasamy, S Suresh, R Mohmood, YL Ramachandra, A Pandey, BMC Bioinformatics 2006 7 Suppl 5 19 10.1186/1471-2105-7-S5-S19 17254303
106. DOMINO: a database of domain-peptide interactions. A Ceol, A Chatr-Aryamontri, E Santonico, R Sacco, L Castagnoli, G Cesareni, Nucleic Acids Res 2007 35 557 D560 10.1093/nar/gkl961 17135199
107. iSPOT: A web tool to infer the interaction specificity of families of protein modules. B Brannetti, M Helmer-Citterich, Nucleic Acids Res 2003 31 3709 3711 10.1093/nar/gkg592 12824399
108. PDZBase: a protein-protein interaction database for PDZ-domains. T Beuming, L Skrabanek, MY Niv, P Mukherjee, H Weinstein, Bioinformatics 2005 21 827 828 10.1093/bioinformatics/bti098 15513994
109. The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. JB Wallingford, R Habas, Development 2005 132 4421 4436 10.1242/dev.02068 16192308
110. Novel Daple-like protein positively regulates both the Wnt/beta-catenin pathway and the Wnt/JNK pathway in Xenopus. H Kobayashi, T Michiue, A Yukita, H Danno, K Sakurai, A Fukui, A Kikuchi, M Asashima, Mech Dev 2005 122 1138 1153 10.1016/j.mod.2005.05.003 16026968
111. Domain Interaction Footprint: a multi-classification approach to predict domain-peptide interactions. C Schillinger, P Boisguerin, G Krause, Bioinformatics 2009 25 1632 1639 10.1093/bioinformatics/btp264 19376827
112. Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. HJ Chung, YH Huang, LF Lau, RL Huganir, J Neurosci 2004 24 10248 10259 10.1523/JNEUROSCI. 0546-04.2004 15537897
113. Characterization in mammalian brain of a DARPP-32 serine kinase identical to casein kinase II. JA Girault, HC Hemmings Jr, SH Zorn, EL Gustafson, P Greengard, J Neurochem 1990 55 1772 1783 10.1111/j.1471-4159.1990.tb04968.x 2145398
114. Phosphorylation of the postsynaptic density-95 (PSD-95)/discs large/zona occludens-1 binding site of stargazin regulates binding to PSD-95 and synaptic targeting of AMPA receptors. DM Chetkovich, L Chen, TJ Stocker, RA Nicoll, DS Bredt, J Neurosci 2002 22 5791 5796 12122038
115. Phosphorylation of stargazin by protein kinase A regulates its interaction with PSD-95. J Choi, J Ko, E Park, JR Lee, J Yoon, S Lim, E Kim, J Biol Chem 2002 277 12359 12363 10.1074/jbc.M200528200 11805122
116. Phosphorylation of serine-880 in GluR2 by protein kinase C prevents its C terminus from binding with glutamate receptor-interacting protein. S Matsuda, S Mikawa, H Hirai, J Neurochem 1999 73 1765 1768 10.1046/j.1471-4159.1999.731765. x 10501226
117. Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. HJ Chung, J Xia, RH Scannevin, X Zhang, RL Huganir, J Neurosci 2000 20 7258 7267 11007883
118. PICK1 and phosphorylation of the glutamate receptor 2 (GluR2) AMPA receptor subunit regulates GluR2 recycling after NMDA receptor-induced internalization. DT Lin, RL Huganir, J Neurosci 2007 27 13903 13908 10.1523/JNEUROSCI.1750-07.2007 18077702
119. Interaction of LDL receptor-related protein 4 (LRP4) with postsynaptic scaffold proteins via its C-terminal PDZ domain-binding motif, and its regulation by Ca/calmodulin-dependent protein kinase II. QB Tian, T Suzuki, T Yamauchi, H Sakagami, Y Yoshimura, S Miyazawa, K Nakayama, F Saitoh, JP Zhang, Y Lu, H Kondo, S Endo, Eur J Neurosci 2006 23 2864 2876 10.1111/j.1460-9568.2006. 04846.x 16819975
120. Akt phosphorylates connexin43 on Ser373, a "Mode-1" binding site for 14-3-3. DJ Park, CJ Wallick, KD Martyn, AF Lau, C Jin, BJ Warn-Cramer, Cell Communication and Adhesion 2007 14 211 226 10.1080/15419060701755958 18163231
121. Connexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation. JL Solan, MD Fry, EM TenBroek, PD Lampe, J Cell Sci 2003 116 2203 2211 10.1242/jcs.00428 12697837
122. Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. JL Solan, PD Lampe, Biochim Biophys Acta 2005 1711 154 163 10.1016/j.bbamem.2004.09.013 15955300
123. A proteomic analysis of cell signaling alterations in colorectal cancer. J Madoz-Gurpide, M Canamero, L Sanchez, J Solano, P Alfonso, JI Casal, Mol Cell Proteomics 2007
124. Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC. JL Solan, L Marquez-Rosado, PL Sorgen, PJ Thornton, PR Gafken, PD Lampe, J Cell Biol 2007 179 1301 1309 10.1083/jcb.200707060 18086922
125. Connexin43 phosphorylation: structural changes and biological effects. JL Solan, PD Lampe, Biochem J 2009 419 261 272 10.1042/BJ20082319 19309313
126. Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. NB Adey, L Huang, PA Ormonde, ML Baumgard, R Pero, DV Byreddy, SV Tavtigian, PL Bartel, Cancer Res 2000 60 35 37 10646847
127. Regulation of NR1/NR2C N-methyl-D-aspartate (NMDA) receptors by phosphorylation. BS Chen, S Braud, JD Badger, JT Isaac, KW Roche, J Biol Chem 2006 281 16583 16590 10.1074/jbc.M513029200 16606616
128. Dynamic scaffolding in a g protein-coupled signaling system. P Mishra, M Socolich, MA Wall, J Graves, Z Wang, R Ranganathan, Cell 2007 131 80 92 10.1016/j.cell.2007.07.037 17923089
129. Dynamic regulation of the INAD signaling scaffold becomes crystal clear. C Montell, Cell 2007 131 19 21 10.1016/j.cell.2007.09.022 17923082
130. Dual role of CaMKII-dependent SAP97 phosphorylation in mediating trafficking and insertion of NMDA receptor subunit NR2A. D Mauceri, F Gardoni, E Marcello, LM Di, J Neurochem 2007 100 1032 1046 10.1111/j.1471-4159.2006.04267. x 17156128
131. Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. P Steiner, MJ Higley, W Xu, BL Czervionke, RC Malenka, BL Sabatini, Neuron 2008 60 788 802 10.1016/j.neuron.2008.10.014 19081375
132. The role of the NHERF family of PDZ scaffolding proteins in the regulation of salt and water transport. U Seidler, AK Singh, A Cinar, M Chen, J Hillesheim, B Hogema, B Riederer, Ann N Y Acad Sci 2009 1165 249 260 10.1111/j.1749-6632.2009.04046.x 19538313
133. Phosphorylation of PDZ1 domain attenuates NHERF-1 binding to cellular targets. JW Voltz, M Brush, S Sikes, D Steplock, EJ Weinman, S Shenolikar, J Biol Chem 2007 282 33879 33887 10.1074/jbc.M703481200 17895247
134. Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor-1. EJ Weinman, RS Biswas, Q Peng, L Shen, CLEX Turner, D Steplock, S Shenolikar, R Cunningham, J Clin Invest 2007 117 3412 3420 10.1172/JCI32738 17975671
135. A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions. V Raghuram, H Hormuth, JK Foskett, Proc Natl Acad Sci USA 2003 100 9620 9625 10.1073/pnas.1633250100 12881487
136. Protein kinase C phosphorylation disrupts Na+/H+ exchanger regulatory factor 1 autoinhibition and promotes cystic fibrosis transmembrane conductance regulator macromolecular assembly. J Li, PI Poulikakos, Z Dai, JR Testa, DJ Callaway, Z Bu, J Biol Chem 2007 282 27086 27099 10.1074/jbc.M702019200 17613530
137. The scaffold protein PDZK1 undergoes a head-to-tail intramolecular association that negatively regulates its interaction with EBP50. D Lalonde, A Bretscher, Biochemistry 2009 19173579
138. Crystallographic characterization of the radixin FERM domain bound to the C-terminal region of the human Na+/H+-exchanger regulatory factor (NHERF). S Terawaki, R Maesaki, K Okada, T Hakoshima, Acta Crystallogr D Biol Crystallogr 2003 59 177 179 10.1107/S0907444902019686 12499563
139. Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1. H Cheng, J Li, R Fazlieva, Z Dai, Z Bu, H Roder, Structure 2009 17 660 669 10.1016/j.str.2009.03.009 19446522
140. Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1. J Li, DJ Callaway, Z Bu, J Mol Biol 2009 392 166 180 10.1016/j.jmb.2009.07.005 19591839
141. Crystal structures of autoinhibitory PDZ domain of Tamalin: implications for metabotropic glutamate receptor trafficking regulation. T Sugi, T Oyama, T Muto, S Nakanishi, K Morikawa, H Jingami, EMBO J 2007 26 2192 2205 10.1038/sj.emboj.7601651 17396155
142. The X11/Mint family of adaptor proteins. B Rogelj, JC Mitchell, CC Miller, DM McLoughlin, Brain Res Rev 2006 52 305 315 10.1016/j.brainresrev.2006. 04.005 16764936
143. Interaction of GRASP, a protein encoded by a novel retinoic acid-induced gene, with members of the cytohesin family of guanine nucleotide exchange factors. DJ Nevrivy, VJ Peterson, D Avram, JE Ishmael, SG Hansen, P Dowell, DE Hruby, MI Dawson, M Leid, J Biol Chem 2000 275 16827 16836 10.1074/jbc.275.22. 16827 10828067
144. Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins. J Kitano, K Kimura, Y Yamazaki, T Soda, R Shigemoto, Y Nakajima, S Nakanishi, J Neurosci 2002 22 1280 1289 11850456
145. Tamalin is a scaffold protein that interacts with multiple neuronal proteins in distinct modes of protein-protein association. J Kitano, Y Yamazaki, K Kimura, T Masukado, Y Nakajima, S Nakanishi, J Biol Chem 2003 278 14762 14768 10.1074/jbc.M300184200 12586822
146. Phosphorylation and recruitment of Syk by immunoreceptor tyrosine-based activation motif-based phosphorylation of tamalin. M Hirose, J Kitano, Y Nakajima, K Moriyoshi, S Yanagi, H Yamamura, T Muto, H Jingami, S Nakanishi, J Biol Chem 2004 279 32308 32315 10.1074/jbc.M400547200 15173175
147. Ligand-dependent dynamics and intramolecular signaling in a PDZ domain. EJ Fuentes, CJ Der, AL Lee, J Mol Biol 2004 335 1105 1115 10.1016/j.jmb.2003.11. 010 14698303
148. Evaluation of energetic and dynamic coupling networks in a PDZ domain protein. EJ Fuentes, SA Gilmore, RV Mauldin, AL Lee, J Mol Biol 2006 364 337 351 10.1016/j.jmb.2006.08.076 17011581
149. Conservation of side-chain dynamics within a protein family. AB Law, EJ Fuentes, AL Lee, J Am Chem Soc 2009 131 6322 6323 10.1021/ja809915a 19374353
150. Reassessing a sparse energetic network within a single protein domain. CN Chi, L Elfstrom, Y Shi, T Snall, A Engstrom, P Jemth, Proc Natl Acad Sci USA 2008 105 4679 4684 10.1073/pnas.0711732105 18339805
151. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. M Aarts, Y Liu, L Liu, S Besshoh, M Arundine, JW Gurd, YT Wang, MW Salter, M Tymianski, Science 2002 298 846 850 10.1126/science.1072873 12399596
152. Making protein interactions druggable: targeting PDZ domains. KK Dev, Nat Rev Drug Discov 2004 3 1047 1056 10.1038/nrd1578 15573103
153. Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. M Wolde, A Fellows, J Cheng, A Kivenson, B Coutermarsh, L Talebian, K Karlson, A Piserchio, DF Mierke, BA Stanton, WB Guggino, DR Madden, J Biol Chem 2007 282 8099 8109 10.1074/jbc.M611049200 17158866
154. Roles of NHERF1/EBP50 in cancer. MM Georgescu, FC Morales, JR Molina, Y Hayashi, Curr Mol Med 2008 8 459 468 10.2174/156652408785748031 18781953
155. NHERF1: molecular brake on the PI3K pathway in breast cancer. MM Georgescu, Breast Cancer Res 2008 10 106 10.1186/bcr1992 18430260
156. The PDZ domain of PICK1 differentially accepts protein kinase C-alpha and GluR2 as interacting ligands. KK Dev, S Nakanishi, JM Henley, J Biol Chem 2004 279 41393 41397 10.1074/jbc.M404499200 15247289
157. Identification of a specific inhibitor of the dishevelled PDZ domain. J Shan, DL Shi, J Wang, J Zheng, Biochemistry 2005 44 15495 15503 10.1021/bi0512602 16300398
158. Beta strand peptidomimetics as potent PDZ domain ligands. MC Hammond, BZ Harris, WA Lim, PA Bartlett, Chem Biol 2006 13 1247 1251 10.1016/j.chembiol. 2006.11.010 17185220
159. An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. N Fujii, L You, Z Xu, K Uematsu, J Shan, B He, I Mikami, LR Edmondson, G Neale, J Zheng, RK Guy, DM Jablons, Cancer Res 2007 67 573 579 10.1158/0008-5472.CAN-06-2726 17234765
160. Optimizing Dvl PDZ domain inhibitor by exploring chemical space. J Shan, JJ Zheng, J Comput Aided Mol Des 2009 23 37 47 10.1007/s10822-008-9236-1 18780146
161. Bridged peptide macrocycles as ligands for PDZ domain proteins. G Udugamasooriya, D Saro, MR Spaller, Org Lett 2005 7 1203 1206 10.1021/ol0475966 15787467
162. A chemical library approach to organic-modified peptide ligands for PDZ domain proteins: a synthetic, thermodynamic and structural investigation. DG Udugamasooriya, SC Sharma, MR Spaller, Chembiochem 2008 9 1587 1589 10.1002/cbic.200800126 18506876
163. Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction. A Bach, CN Chi, TB Olsen, SW Pedersen, MU Roder, GF Pang, RP Clausen, P Jemth, K Stromgaard, J Med Chem 2008 51 6450 6459 10.1021/jm800836w 18811137
164. Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. LL Blazer, RR Neubig, Neuropsychopharmacology 2009 34 126 141 10.1038/npp.2008.151 18800065
165. Disrupting specific PDZ domain-mediated interactions for therapeutic benefit. MD Houslay, Br J Pharmacol 2009 158 483 485 10.1111/j.1476-5381.2009. 00359.x 19732060
166. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin. JJ Grootjans, G Reekmans, H Ceulemans, G David, J Biol Chem 2000 275 19933 19941 10.1074/jbc.M002459200 10770943
167. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. V Raghuram, DO Mak, JK Foskett, Proc Natl Acad Sci USA 2001 98 1300 1305 10.1073/pnas.031538898 11158634
168. Schwannomin isoform-1 interacts with syntenin via PDZ domains. M Jannatipour, P Dion, S Khan, H Jindal, X Fan, J Laganiere, AH Chishti, GA Rouleau, J Biol Chem 2001 276 33093 33100 10.1074/jbc.M105792200 11432873
169. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Y Xue, J Ren, X Gao, C Jin, L Wen, X Yao, Mol Cell Proteomics 2008 7 1598 1608 10.1074/mcp.M700574-MCP200 18463090
170. Proteome-wide prediction of PKA phosphorylation sites in eukaryotic kingdom. X Gao, C Jin, J Ren, X Yao, Y Xue, Genomics 2008 92 457 463 10.1016/j.ygeno.2008.08.013 18817865
171. Phosphoproteomic analysis of the developing mouse brain. BA Ballif, J Villen, SA Beausoleil, D Schwartz, SP Gygi, Mol Cell Proteomics 2004 3 1093 1101 10.1074/mcp.M400085-MCP200 15345747
172. Large-scale characterization of HeLa cell nuclear phosphoproteins. SA Beausoleil, M Jedrychowski, D Schwartz, JE Elias, J Villen, J Li, MA Cohn, LC Cantley, SP Gygi, Proc Natl Acad Sci USA 2004 101 12130 12135 10.1073/pnas.0404720101 15302935
173. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. D Schwartz, SP Gygi, Nat Biotechnol 2005 23 1391 1398 10.1038/nbt1146 16273072
174. PTEN acetylation modulates its interaction with PDZ domain. T Ikenoue, K Inoki, B Zhao, KL Guan, Cancer Res 2008 68 6908 6912 10.1158/0008-5472.CAN-08- 1107 18757404
175. CSS-Palm 2.0: an updated software for palmitoylation sites prediction. J Ren, L Wen, X Gao, C Jin, Y Xue, X Yao, Protein Eng Des Sel 2008 21 639 644 10.1093/protein/gzn039 18753194
176. Systematic study of protein sumoylation: Development of a site-specific predictor of SUMOsp 2.0. J Ren, X Gao, C Jin, M Zhu, X Wang, A Shaw, L Wen, X Yao, Y Xue, Proteomics 2009 9 3409 3412 10.1002/pmic.200800646 19504496
177. PDZ domains of Par-3 as potential phosphoinositide signaling integrators. H Wu, W Feng, J Chen, LN Chan, S Huang, M Zhang, Mol Cell 2007 28 886 898 10.1016/j.molcel.2007.10.028 18082612
178. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane. P Zimmermann, K Meerschaert, G Reekmans, I Leenaerts, JV Small, J Vandekerckhove, G David, J Gettemans, Mol Cell 2002 9 1215 1225 10.1016/S1097-2765(02)00549-X 12086619
179. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6. P Zimmermann, Z Zhang, G Degeest, E Mortier, I Leenaerts, C Coomans, J Schulz, F N'Kuli, PJ Courtoy, G David, Dev Cell 2005 9 377 388 10.1016/j.devcel.2005.07.011 16139226
180. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions. E Mortier, G Wuytens, I Leenaerts, F Hannes, MY Heung, G Degeest, G David, P Zimmermann, EMBO J 2005 24 2556 2565 10.1038/sj.emboj.7600722 15961997
181. The prevalence and significance of PDZ domain-phosphoinositide interactions. P Zimmermann, Biochim Biophys Acta 2006 1761 947 956 16884951
182. The PDZ2 domain of zonula occludens -1 and -2 is a phosphoinositide binding domain. K Meerschaert, MP Tun, E Remue, GA De, C Boucherie, B Vanloo, G Degeest, J Vandekerckhove, P Zimmermann, N Bhardwaj, H Lu, W Cho, J Gettemans, Cell Mol Life Sci 2009 19784548
183. Structural Diversity of PDZ-Lipid Interactions. R Gallardo, Y Ivarsson, J Schymkowitz, F Rousseau, P Zimmermann, Chembiochem 2010 11 456 467 10.1002/cbic.200900616 20091728
184. SMART, a simple modular architecture research tool: identification of signaling domains. J Schultz, F Milpetz, P Bork, CP Ponting, Proc Natl Acad Sci USA 1998 95 5857 5864 10.1073/pnas.95.11.5857 9600884
185. Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide. H Tochio, Q Zhang, P Mandal, M Li, M Zhang, Nat Struct Biol 1999 6 417 421 10.1038/8216 10331866
186. Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain. H Tochio, YK Mok, Q Zhang, HM Kan, DS Bredt, M Zhang, J Mol Biol 2000 303 359 370 10.1006/jmbi.2000.4148 11031113
187. Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation. NA Cohen, JE Brenman, SH Snyder, DS Bredt, Neuron 1996 17 759 767 10.1016/S0896-6273(00)80207-X 8893032
188. Identifying protein kinase C substrates: an introduction. A Toker, Methods Mol Biol 2003 233 247 251 12840512
189. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. RB Pearson, BE Kemp, Methods Enzymol 1991 200 62 81 full-text 1956339